Sun: Teva rises despite FDA letter

Energy exploration shares were steady ahead of results of drilling tests at Leviathan, which are expected within days.

The Tel Aviv Stock Exchange (TASE) rose today. The Tel Aviv 25 Index rose 0.2% to 1307.44 points, the Tel Aviv 100 Index rose 0.2% to 1208 points, and the Tel-Tech Index fell 0.35% to 246.81 points. Turnover was NIS 1.21 billion.

Isramco Ltd. (Nasdaq: ISRL; TASE: ISRA.L) units rose 3.8%.

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) rose 2.9%, despite an FDA letter at the end of last week, which did not authorize a lower volume version of Copaxone.

Energy exploration shares were steady ahead of results expected within days of drilling tests at Leviathan. Delek Drilling LP (TASE: DEDR.L) rose 0.2%, and Avner Oil and Gas LP (TASE: AVNR.L) was unchanged. The parent company of both those two units, Delek Group Ltd. (TASE: DLEKG), rose 1.2%. Ratio Oil Exploration (1992) LP (TASE:RATI.L) fell 4%.

Excellence Investments Ltd. (TASE: EXCE) today raised its target price on Paz Oil Company Ltd. (TASE:PZOL), and reiterated an "Outperform" rating. Paz shares rose 1%.

The corporate bond benchmark Tel-Bond 60 Index fell 0.5%. Long-term Shahar unlinked bonds fell by up to 0.1% and long-term Galil CPI-linked bonds fell by up to 0.5%.

Published by Globes [online], Israel business news - www.globes-online.com - on December 26, 2010

© Copyright of Globes Publisher Itonut (1983) Ltd. 2010

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018